Clinical Trial Update: Activated Protein C in Acute Stroke Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating activated protein C for acute stroke was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xigris (drotrecogin alfa activated) (drotrecogin alfa activated)

Snippet

Sponsor: University of Rochester | Conditions: Stroke | Phase 2 | Status: TERMINATED | Results posted: 2016-10-24